Jing Wang
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Childhood Cancer Survivors' Quality of Life, Lung Cancer Research Studies
Most-Cited Works
- → Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia(2018)49 cited
- → Epithelioid Trophoblastic Tumors: Treatments, Outcomes, and Potential Therapeutic Targets(2018)47 cited
- → Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1(2020)18 cited
- → ETS1 and SP1 drive DHX15 expression in acute lymphoblastic leukaemia(2018)12 cited
- → CD20 expression sub-stratifies standard-risk patients with B cell precursor acute lymphoblastic leukemia(2017)11 cited
- → PRPS2 mutations drive acute lymphoblastic leukemia relapse through influencing PRPS1/2 hexamer stability(2022)6 cited
- → [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center].(2015)6 cited
- → The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review(2022)5 cited
- → [CD20 Expression in Adult Patients with B-lineage Acute Lymphoblastic Leukemia and Its Prognostic Significance].(2015)4 cited
- → Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia(2021)1 cited